Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

This grant funds clinical trials of products that evaluate efficacy and/or safety to support a new indication or labeling change for rare diseases or conditions. It aims to support collaborative, efficient, and innovative trials that can increase approved treatments and positively impact rare disease drug development.

Amount: up to $900,000
Type: Grant

Key facts

Key facts for Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Amount	up to $900,000
Issuer	Food and Drug Administration
Who can apply	Organizations
Sectors	Agriculture
Deadline	Closes 16 May 2028

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 18 hours ago

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026